Withania somnifera and the Liver

The Therapuetic Goods Administration (TGA) recently conducted a safety investigation and literature review of Withania somnifera and its impact on the liver. Based on these findings, the NHAA has compiled a list of prescribing recommendations for our practitioner members. 

Please log in to the members area to access this important prescribing update.